Stay informed with the latest litigation news. Explore now

IP Verse

Novartis Pharmaceuticals Corporation V. Teva Pharmaceuticals, Inc. - 1:25-cv-00928

Explore the details of the Novartis Pharmaceuticals Corporation V. Teva Pharmaceuticals, Inc. case under case number 1:25-cv-00928 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25-cv-00928
Filing Date
Jul 24, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Teva Pharmaceuticals, Inc. -
Novartis Pharmaceuticals Corporation -

Patents Involved

This case involves 4 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US9271941B2
-US9155706B2
-US8580304B2
-US9399021B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 24, 2025Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (mpb) (Entered: 07/25/2025)PACER Document
Jul 24, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,580,304; 9,155,706; 9,271,941; 9,399,021. (mpb) (Entered: 07/25/2025)PACER Document
Jul 24, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/10/2025. Date of Expiration of Patent: 1/28/2032.Thirty Month Stay Deadline: 12/10/2027. (mpb) (Entered: 07/25/2025)PACER Document
Jul 24, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 07/25/2025)PACER Document
Jul 24, 2025COMPLAINT against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4742630) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits A-D, # 2 Civil Cover Sheet)(mpb) (Entered: 07/25/2025)PACER Document
Jul 24, 2025No Summons Issued. (mpb)PACER Document
Jul 30, 2025Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (alb)PACER Document
Jul 24, 2025COMPLAINT against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4742630) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits A-D, # 2 Civil Cover Sheet)(mpb) (Entered: 07/25/2025)Attachment
Jul 24, 2025COMPLAINT against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4742630) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits A-D, # 2 Civil Cover Sheet)(mpb) (Entered: 07/25/2025)Attachment